Corona Remedies Share Price: 38% Premium IPO Debut
Corona Remedies Share Price lists at 38% premium over IPO price. 137x subscription, ₹1,470/share on NSE. Strong pharma IPO performance.
Tag pharma investment
Corona Remedies Share Price lists at 38% premium over IPO price. 137x subscription, ₹1,470/share on NSE. Strong pharma IPO performance.
